DOST names 13 hospitals involved in WHO COVID-19 vaccine solidarity trials

Robie de Guzman   •   September 22, 2020   •   1099

MANILA, Philippines – The Department of Science and Technology (DOST) on Tuesday announced that 13 hospitals will be involved in the solidarity trials of the World Health Organization (WHO) for potential novel coronavirus disease (COVID-19) vaccines in the country.

In a statement, DOST Secretary Fortunato dela Peña said the Inter-Agency Task Force for the Management of Emerging Infectious Disease (IATF-MEID) has adopted the agency’s recommendation for zoning on the solidarity trials for the vaccine candidates against COVID-19 which will be conducted this year.

Dela Peña said the vaccine candidates will be tested in eight trial zones, involving a total of 13 hospitals.

He identified these facilities as the Philippine General Hospital, Manila Doctors Hospital, San Lazaro Hospital, Lung Center of the Philippines, St. Luke’s Medical Center-Quezon City, the Research Institute for Tropical Medicine, Makati Medical Center, The Medical City, and St. Luke’s Medical Center-BGC, Vicente Sotto Memorial Medical Center, Chong Hua Hospital in Cebu City, De La Salle Health Sciences Institute in Cavite, and Southern Philippines Medical Center in Davao City.

The WHO solidarity trials will start this October and expected to be completed by the second quarter of the following year.

The DOST chief also confirmed that the Philippines is in agreement with five COVID- 19 vaccine developers that will enable clinical trial data sharing.

PH expects to receive 190K doses of Sputnik V vaccine this September – Galvez

Robie de Guzman   •   September 17, 2021

MANILA, Philippines – Around 190,000 doses of Sputnik V COVID-19 vaccine (component 2) manufactured by Russian firm Gamaleya Research Institute are expected to arrive in the country this month, vaccine czar Carlito Galvez Jr. said Friday.

Galvez said the additional vaccine supply may be delivered by the weekend or early next week.

“This shipment of Sputnik V vaccines shall be used for the second dose. After this, we will be receiving the single-shot Sputnik V Light as we move forward with our vaccine rollout,” he said.

Galvez, who is also the chief implementer of the National Task Force (NTF) against COVID-19, eased concerns among those who have already received their first dose of Sputnik V.

“As per our vaccine experts from the Department of Health, the gap between first and second doses of Sputnik V can be as long as six months, so no need to worry because the vaccines are arriving soon,” Galvez explained.

This month, the country expects to receive the first batch of government-procured Sputnik V Light vaccines consisting of 1 million doses.

“The Sputnik V Light is more efficient because we will be able to protect more people faster. This would eliminate the problem wherein people fail to return for their second dose,” Galvez noted.

As of September 15, the country has received a total of 57,547,610 vaccine doses from various manufacturers, of which over 36 million doses were procured by the national government.

The country has also breached the 40 million mark in terms of COVID-19 jabs administered, with 40,030,388 shots given as of September 15. Of this number, 17,675,959 were fully vaccinated and 22,354,429 received their first dose.

Over 753K additional doses of Pfizer vaccine arrive in PH

Robie de Guzman   •   September 16, 2021

 

MANILA, Philippines — The Philippines on Wednesday night received a total of 753,480 additional doses of COVID-19 vaccine manufactured by the US-based firm Pfizer, the National Task Force (NTF) against COVID-19 said.

A part of the shipment, around 51,480 doses were first unloaded in Cebu while the rest arrived at the Ninoy Aquino International Airport around 9 p.m.

The newly delivered vaccine shots will be transported to a storage facility in Marikina City.

The NTF said 51,480 of these doses will be distributed to Davao City on Thursday.

The Philippines has so far received around 56.7 million doses of COVID-19 vaccines from various manufacturers since February.

WHO reiterates need to address vaccine inequity to end COVID-19 pandemic

Aileen Cerrudo   •   September 15, 2021

The World Health Organization (WHO) continues its call to address vaccine inequity in hopes to end the coronavirus disease (COVID-19) pandemic.

WHO Director-General Dr. Tedros Adhanom Ghebreyesus, in his speech on Tuesday evening (September 14), lamented that of the more than 5.7 billion doses that have been administered globally, only less than 2% have been administered in Africa.

He said that Africa has been left behind when it comes to vaccine rollout.

“There are countries with less than two percent vaccination coverage, most of them in Africa, who are not even getting their first and second dose,” Tedros said.

Dr. Tedros said the lack of vaccines in Africa has a global impact that should be addressed.

“The longer vaccine inequity persists, the more the virus will keep circulating and changing, the longer the social and economic disruption will continue, and the higher the chances that more variants will emerge that render vaccines less effective,” he said.

The WHO calls on vaccine manufacturers to prioritize COVAX and the African COVID-19 Vaccine Acquisition Task Team (AVAT). It also calls on countries that have already achieved high coverage levels to swap their near-term vaccine deliveries with COVAX and AVAT.

The organization’s global targets are to support every country to vaccinate at least 40% of its population by the end of this year, and 70% of the world’s population by the middle of next year. AAC

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.